HEPA(Delisted)
HepionยทNASDAQ
--
--(--)
HEPA Profile
Hepion Pharmaceuticals, Inc.
A biopharmaceutical company that developing multipotent drug therapies for the treatment of chronic liver disease
55 Madison Ave, Suite 400- PMB# 4362, Morristown, New Jersey 07960
--
Hepion Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on May 15, 2013. The company is a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of drug therapies for the treatment of chronic fibrosis-related diseases. The main therapeutic approaches specifically address the disease mechanisms associated with fibrosis and inflammation and show potential for the treatment of non-alcoholic steatohepatitis, hepatocellular carcinoma, viral hepatitis and other fibrotic diseases.
